Baycox Bovis 50mg/ml oral suspension
Baycox Bovis 50mg/ml oral suspension
Not authorised
- Toltrazuril
- Toltrazuril
Product identification
Medicine name:
Baycox Bovis 50mg/ml oral suspension
Baycox Bovis Vet. 50 mg/ml oral suspension
Active substance:
- Toltrazuril
- Toltrazuril
Target species:
-
Cattle
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Toltrazuril50.00/milligram(s)1.00millilitre(s)
-
Toltrazuril50.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP51BC01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Denmark
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
- Danish Medicines Agency
Authorisation number:
- 37659
Date of authorisation status change:
Reference member state:
-
Denmark
Procedure number:
- DK/V/0109/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
PI Baycox Bovis.pdf
English (PDF)
Download Published on: 27/01/2022